Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/25/1998 | EP0825186A1 2-Aminobenzazepine derivatives and their use for the treatment of immunosuppression |
02/25/1998 | EP0825185A1 Pyridine fused to a bicyclic ring |
02/25/1998 | EP0825184A1 Heterocyclic derivatives as platelet aggregation inhibitors |
02/25/1998 | EP0825180A1 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives, process for producing the same, and medicinal composition containing the same |
02/25/1998 | EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them |
02/25/1998 | EP0825177A1 New seco-D steroids active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
02/25/1998 | EP0824919A2 Therapeutic methods and compositions for use therein |
02/25/1998 | EP0824918A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-$g(k)B |
02/25/1998 | EP0824917A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis |
02/25/1998 | EP0824916A1 Pranoprofen eyedrops containing organic amine |
02/25/1998 | EP0824915A2 Preparation of glycoglycerolipids, their use as surfactants and cosmetic or dermatological compositions containing them |
02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
02/25/1998 | EP0824590A1 Vasoactive intestinal peptide |
02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
02/25/1998 | EP0824539A1 Dialkyltiacumicin compounds |
02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
02/25/1998 | EP0824536A1 Antimalarial organometallic iron complexes |
02/25/1998 | EP0824535A1 Antibacterial cephalosporins |
02/25/1998 | EP0824534A1 9,10 disubstituted camptothecin derivatives with antitumor activity |
02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
02/25/1998 | EP0824529A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them |
02/25/1998 | EP0824527A1 Quinazoline derivatives |
02/25/1998 | EP0824526A1 Quinazoline derivative |
02/25/1998 | EP0824525A1 Quinazoline derivatives |
02/25/1998 | EP0824524A1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
02/25/1998 | EP0824523A1 Nitric oxide synthase inhibitors derived from cyclic amidines |
02/25/1998 | EP0824519A1 Beta-adrenergic agonists |
02/25/1998 | EP0824515A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them |
02/25/1998 | EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
02/25/1998 | EP0824356A1 Pharmaceutical compositions for the treatment of alcohol addiction |
02/25/1998 | EP0824354A1 Methods to inhibit late radiation-induced skin damage |
02/25/1998 | EP0824353A1 Methods to inhibit acute radiation-induced skin damage |
02/25/1998 | EP0824352A1 Cyclodextrin compounds and methods of making and use thereof |
02/25/1998 | EP0824351A1 A pharmaceutical composition useful in treating alcohol dependence or abuse comprising at least one partial agonist of 5-th1a receptors and at least one selective inhibitor of monoamino-oxidase |
02/25/1998 | EP0824350A1 Antifungal composition |
02/25/1998 | EP0824348A1 Treatment of psoriasis with 11-cis-retinoic acid |
02/25/1998 | EP0824347A1 Injury and mucous membrane antiseptics containing magnesium perphthalate |
02/25/1998 | EP0824346A2 Use of sesquiterpenes for inhibiting oxidative enzymes |
02/25/1998 | EP0824341A1 Prevention of tooth loss by the administration of alendronate or its salts |
02/25/1998 | EP0824316A1 Compositions and methods for stimulating hair growth |
02/25/1998 | EP0721447B1 Anthracene derivatives for use as anticancer agent or dye |
02/25/1998 | EP0713490B1 C-22 ring stabilized rapamycin derivatives |
02/25/1998 | EP0705259B1 Phenyrrole derivatives and their use as dopamine d3 antagonists |
02/25/1998 | EP0702673B1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders |
02/25/1998 | EP0697019B1 Risperidone pamoate |
02/25/1998 | EP0581916B1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
02/25/1998 | CN1174558A Tumor necrosis factor-Gamma |
02/25/1998 | CN1174557A Keratan sulfate oligosaccharide fraction and drug containing the same |
02/25/1998 | CN1174554A Rapamycin 42-oximes and hydroxylamines |
02/25/1998 | CN1174549A Indole derivative |
02/25/1998 | CN1174548A Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
02/25/1998 | CN1174513A Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
02/25/1998 | CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
02/25/1998 | CN1174505A Pharmaceutical composition comprising lamotrigine |
02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
02/25/1998 | CN1174196A Heterocyclic-fused pyridines |
02/25/1998 | CN1174194A Novel derivative of kojic acid and its use as depigmenting agent |
02/25/1998 | CN1174193A Microbicidal triazolyl derivative |
02/25/1998 | CN1174192A New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them |
02/25/1998 | CN1174190A Diaryl alkane derivatives containing alicyclic group, their preparation and their therapeutic and prophylactic uses |
02/25/1998 | CN1174045A Drug for preventing and treating tinea, smelly foot and infectious skin disease |
02/25/1998 | CN1174040A Compound antibacterial and antiviral veterinary medicine capable of raising immunity |
02/25/1998 | CN1174034A Nutritious trace element capsule for curing rheumatoid disease |
02/25/1998 | CN1174032A Compound vitamin drop for infant |
02/25/1998 | CN1174031A Diclofenac sodium skin-penetrating delayed plaster |
02/25/1998 | CN1174030A Triphenyl diamidine enteric coated tablet as vermifuge |
02/25/1998 | CN1174027A Cosmetics composition with paste fat and volatile compound |
02/25/1998 | CN1037512C Imidazolyl-substituted cyclohexane derivatives, prep. and use thereof |
02/25/1998 | CN1037511C Prep. of 1 -( aralkyl amino-alkyl) imidazole compounds |
02/25/1998 | CN1037510C Prep. of indole derivatives |
02/24/1998 | US5721366 Phenylamidine derivatives |
02/24/1998 | US5721365 N-substituted piperazine NONOates |
02/24/1998 | US5721362 Process for producing ecteinascidin compounds |
02/24/1998 | US5721359 Cephalosporin antibiotics |
02/24/1998 | US5721357 Depolymerizing heparin ester by action of a base to form sulfated oligosaccharides |
02/24/1998 | US5721356 Orally active adenosine kinase inhibitors |
02/24/1998 | US5721349 Genetically altered mutant strain |
02/24/1998 | US5721347 Esters and amides of substituted pyrrole acetic acids |
02/24/1998 | US5721346 Compounds of the secomacrolide and secoazalide class and a process for the preparation thereof |
02/24/1998 | US5721337 Human thymosin β15 |
02/24/1998 | US5721278 Administering clomiphene and nitric oxide inducer |
02/24/1998 | US5721276 Treating disorders of melatoninergic system |
02/24/1998 | US5721275 Slow release vehicles for minimizing skin irritancy of topical compositions |
02/24/1998 | US5721273 Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension |
02/24/1998 | US5721271 Parasiticidal milbemycin derivatives |
02/24/1998 | US5721270 Drugs for allergic and eosinophilic diseases |
02/24/1998 | US5721267 Chemotherapeutic pyrrolocarbazole derivatives |
02/24/1998 | US5721266 Substituted imidazolinyl-imidazolines as antagonists of SH-2 binding and therapeutic uses thereof |
02/24/1998 | US5721263 Angiotensin ii antagonist in combination with diuretic or calcium antagonist; treating hypertension |
02/24/1998 | US5721260 Heterocyclic compounds |
02/24/1998 | US5721259 antitumor agent; leukemia; 3-amino-2-formylpyridine thiosemicarbazone |
02/24/1998 | US5721258 Antagonist of n-methyl-d-aspartate |
02/24/1998 | US5721257 Transdermal and transmucosal administration of nicotine concurrently; high speed response |
02/24/1998 | US5721256 Inhibitors of the enzyme activity associated with immunophilin proteins |
02/24/1998 | US5721255 Useful for preventing pain, anxiety, migrane, schizophrenia, asthma, rheumatoid arthritis, fibrositis, or ulcerative colitis in mammal |
02/24/1998 | US5721254 Antiinflammatory agents; analgesics |
02/24/1998 | US5721253 Fibrinogen receptor antagonists |
02/24/1998 | US5721252 5HT1F agonists for the treatment of migraine |